Dr Reddys Laboratories annual capital expenditures (capex)
2018
2019
2020
2021
2022
2023
2024
2025
Dr Reddys Laboratories Capital Expenditures (CapEx) Growth & History (RDY)
Dr Reddys Laboratories's capital expenditures (capex) was $322.0M for fiscal 2025.
View full Dr Reddys Laboratories company overviewDr Reddys Laboratories annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-03-31 | $322.0M | $125.0M | +63.45% |
| 2024 | 2024-03-31 | $197.0M | $59.0M | +42.75% |
| 2023 | 2023-03-31 | $138.0M | −$55.0M | −28.50% |
| 2022 | 2022-03-31 | $193.0M | $60.0M | +45.11% |
| 2021 | 2021-03-31 | $133.0M | $69.0M | +107.81% |
| 2020 | 2020-03-31 | $64.0M | −$37.0M | −36.63% |
| 2019 | 2019-03-31 | $101.0M | −$42.0M | −29.37% |
| 2018 | 2018-03-31 | $143.0M | — | — |
Dr Reddys Laboratories capital expenditures (capex) trends
Over the last five fiscal years, Dr Reddys Laboratories's capital expenditures (capex) increased from $64.0M to $322.0M, a change of $258.0M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dr Reddys Laboratories source filings ↗